Reported Earnings • Aug 06
Second quarter 2026 earnings released: EPS: JP¥13.19 (vs JP¥23.88 in 2Q 2025) Second quarter 2026 results: EPS: JP¥13.19 (down from JP¥23.88 in 2Q 2025). Revenue: JP¥3.57b (up 6.7% from 2Q 2025). Net income: JP¥107.0m (down 47% from 2Q 2025). Profit margin: 3.0% (down from 6.1% in 2Q 2025). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 39% per year but the company’s share price has only increased by 9% per year, which means it is significantly lagging earnings growth. Upcoming Dividend • Jun 22
Upcoming dividend of JP¥20.00 per share Eligible shareholders must have bought the stock before 29 June 2026. Payment date: 08 September 2026. Payout ratio is a comfortable 58% but the company is paying out more than the cash it is generating. Trailing yield: 4.3%. Within top quartile of Japanese dividend payers (3.9%). Higher than average of industry peers (1.6%). Annuncio • Jun 03
Create Medic Co., Ltd. to Report Q2, 2026 Results on Aug 05, 2026 Create Medic Co., Ltd. announced that they will report Q2, 2026 results on Aug 05, 2026 Reported Earnings • May 08
First quarter 2026 earnings released: EPS: JP¥18.36 (vs JP¥24.37 in 1Q 2025) First quarter 2026 results: EPS: JP¥18.36 (down from JP¥24.37 in 1Q 2025). Revenue: JP¥3.36b (up 4.5% from 1Q 2025). Net income: JP¥153.0m (down 27% from 1Q 2025). Profit margin: 4.5% (down from 6.5% in 1Q 2025). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 41% per year but the company’s share price has only increased by 8% per year, which means it is significantly lagging earnings growth. Annuncio • May 08
Create Medic Co., Ltd. to Report Q1, 2026 Results on May 07, 2026 Create Medic Co., Ltd. announced that they will report Q1, 2026 results on May 07, 2026 Declared Dividend • Apr 11
Final dividend of JP¥20.00 announced Shareholders will receive a dividend of JP¥20.00. Ex-date: 29th June 2026 Payment date: 8th September 2026 Dividend yield will be 4.0%, which is higher than the industry average of 1.0%. Sustainability & Growth Dividend is covered by earnings (53% earnings payout ratio) but not covered by cash flows (464% cash payout ratio). The dividend has increased by an average of 3.0% per year over the past 10 years and has been stable with no material reductions to payments, indicating a long track record of dividend growth and stability. Earnings per share has grown by 3.6% over the last 5 years. Unless this trend reverses, it should provide support to the dividend and adequate earnings cover. Board Change • Apr 01
Insufficient new directors There is 1 new director who has joined the board in the last 3 years. The company's board is composed of: 1 new director. 3 experienced directors. 3 highly experienced directors. Independent Outside Director Atsuko Kudo was the last director to join the board, commencing their role in 2024. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model. Annuncio • Mar 27
Create Medic Co., Ltd. (TSE:5187) announces an Equity Buyback for 430,000 shares, representing 5.13% for ¥520 million. Create Medic Co., Ltd. (TSE:5187) announces a share repurchase program. Under the program, the company will repurchase up to 430,000 shares, representing 5.13% of its issued share capital for a total price of ¥520 million. The purpose of the program is to further enhance shareholder returns. The program is valid till October 31, 2026. As of December 31, 2025, the company had 8,385,107 shares in issue (excluding treasury stock) and 1,279,220 shares in treasury. New Risk • Feb 18
New minor risk - Dividend sustainability The dividend is not well covered by cash flows. Cash payout ratio: 369% Dividend yield: 3.2% This is considered a minor risk. Dividends are ultimately paid out of the company's available cash reserves. Companies that pay out too much of their cash flow are at risk of having to reduce or cut their dividend in future. If cash flow growth slows or cash flows fall, then there may not be enough cash reserves to maintain the same dividend. Or in extreme cases, companies may opt to take on debt to maintain the dividend. This risk is mitigated by the fact the dividend is covered by earnings, however, cash flows are generally more important. For dividend paying companies, any reduction in the dividend can significantly impact the share price. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 0.8% per year over the past 5 years. Minor Risks Dividend is not well covered by cash flows (369% cash payout ratio). Market cap is less than US$100m (JP¥9.61b market cap, or US$62.7m). Reported Earnings • Feb 15
Full year 2025 earnings released: EPS: JP¥84.17 (vs JP¥95.31 in FY 2024) Full year 2025 results: EPS: JP¥84.17 (down from JP¥95.31 in FY 2024). Revenue: JP¥13.6b (up 4.5% from FY 2024). Net income: JP¥713.0m (down 15% from FY 2024). Profit margin: 5.2% (down from 6.4% in FY 2024). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 41% per year but the company’s share price has only increased by 9% per year, which means it is significantly lagging earnings growth. Annuncio • Feb 13
Create Medic Co., Ltd., Annual General Meeting, Mar 27, 2026 Create Medic Co., Ltd., Annual General Meeting, Mar 27, 2026. Upcoming Dividend • Dec 22
Upcoming dividend of JP¥20.00 per share Eligible shareholders must have bought the stock before 29 December 2025. Payment date: 31 March 2026. Payout ratio is a comfortable 22% and this is well supported by cash flows. Trailing yield: 3.5%. Lower than top quartile of Japanese dividend payers (3.6%). Higher than average of industry peers (1.2%). Annuncio • Dec 11
Create Medic Co., Ltd. to Report Fiscal Year 2025 Results on Feb 13, 2026 Create Medic Co., Ltd. announced that they will report fiscal year 2025 results on Feb 13, 2026 Reported Earnings • Nov 01
Third quarter 2025 earnings released: EPS: JP¥30.19 (vs JP¥22.30 in 3Q 2024) Third quarter 2025 results: EPS: JP¥30.19 (up from JP¥22.30 in 3Q 2024). Revenue: JP¥3.49b (up 8.7% from 3Q 2024). Net income: JP¥254.0m (up 31% from 3Q 2024). Profit margin: 7.3% (up from 6.0% in 3Q 2024). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 34% per year but the company’s share price has only increased by 6% per year, which means it is significantly lagging earnings growth. Declared Dividend • Sep 09
First half dividend of JP¥20.00 announced Dividend of JP¥20.00 is the same as last year. Ex-date: 29th December 2025 Payment date: 31st March 2026 Dividend yield will be 3.7%, which is higher than the industry average of 1.0%. Sustainability & Growth Dividend is covered by both earnings (45% earnings payout ratio) and cash flows (70% cash payout ratio). The dividend has increased over the past 10 years and has been stable with no material reductions to payments, indicating a long track record of dividend growth and stability. Earnings per share has grown by 3.0% over the last 5 years. Unless this trend reverses, it should provide support to the dividend and adequate earnings cover. Reported Earnings • Aug 07
Second quarter 2025 earnings released: EPS: JP¥23.88 (vs JP¥55.31 in 2Q 2024) Second quarter 2025 results: EPS: JP¥23.88 (down from JP¥55.31 in 2Q 2024). Revenue: JP¥3.34b (flat on 2Q 2024). Net income: JP¥203.0m (down 59% from 2Q 2024). Profit margin: 6.1% (down from 15% in 2Q 2024). Over the last 3 years on average, earnings per share has increased by 26% per year but the company’s share price has only increased by 2% per year, which means it is significantly lagging earnings growth. Annuncio • Jul 02
Create Medic Co., Ltd. to Report Q3, 2025 Results on Oct 31, 2025 Create Medic Co., Ltd. announced that they will report Q3, 2025 results on Oct 31, 2025 Upcoming Dividend • Jun 20
Upcoming dividend of JP¥17.00 per share Eligible shareholders must have bought the stock before 27 June 2025. Payment date: 09 September 2025. Payout ratio is a comfortable 32% and this is well supported by cash flows. Trailing yield: 3.9%. Lower than top quartile of Japanese dividend payers (4.0%). Higher than average of industry peers (1.4%). Reported Earnings • May 08
First quarter 2025 earnings released: EPS: JP¥24.37 (vs JP¥6.51 in 1Q 2024) First quarter 2025 results: EPS: JP¥24.37 (up from JP¥6.51 in 1Q 2024). Revenue: JP¥3.22b (up 8.2% from 1Q 2024). Net income: JP¥209.0m (up 254% from 1Q 2024). Profit margin: 6.5% (up from 2.0% in 1Q 2024). Over the last 3 years on average, earnings per share has increased by 16% per year but the company’s share price has remained flat, which means it is significantly lagging earnings. Declared Dividend • Apr 11
Final dividend of JP¥17.00 announced Shareholders will receive a dividend of JP¥17.00. Ex-date: 27th June 2025 Payment date: 9th September 2025 Dividend yield will be 4.1%, which is higher than the industry average of 1.0%. Sustainability & Growth Dividend is well covered by both earnings (37% earnings payout ratio) and cash flows (18% cash payout ratio). The dividend has increased over the past 10 years and has been stable with no material reductions to payments, indicating a long track record of dividend growth and stability. Earnings per share has grown by 4.7% over the last 5 years. Unless this trend reverses, it should provide support to the dividend and adequate earnings cover. Annuncio • Apr 05
Create Medic Co., Ltd. to Report Q2, 2025 Results on Aug 05, 2025 Create Medic Co., Ltd. announced that they will report Q2, 2025 results on Aug 05, 2025 Reported Earnings • Feb 15
Full year 2024 earnings released: EPS: JP¥95.31 (vs JP¥16.92 in FY 2023) Full year 2024 results: EPS: JP¥95.31 (up from JP¥16.92 in FY 2023). Revenue: JP¥13.0b (up 3.5% from FY 2023). Net income: JP¥840.0m (up 446% from FY 2023). Profit margin: 6.4% (up from 1.2% in FY 2023). Over the last 3 years on average, earnings per share has fallen by 4% per year whereas the company’s share price has fallen by 2% per year. Annuncio • Feb 05
Create Medic Co., Ltd. to Report Q1, 2025 Results on May 07, 2025 Create Medic Co., Ltd. announced that they will report Q1, 2025 results on May 07, 2025 Annuncio • Jan 03
Create Medic Co., Ltd. to Report Fiscal Year 2024 Results on Feb 13, 2025 Create Medic Co., Ltd. announced that they will report fiscal year 2024 results on Feb 13, 2025 Reported Earnings • Nov 02
Third quarter 2024 earnings released: EPS: JP¥22.30 (vs JP¥33.72 loss in 3Q 2023) Third quarter 2024 results: EPS: JP¥22.30 (up from JP¥33.72 loss in 3Q 2023). Revenue: JP¥3.21b (up 2.2% from 3Q 2023). Net income: JP¥194.0m (up JP¥501.0m from 3Q 2023). Profit margin: 6.0% (up from net loss in 3Q 2023). Over the last 3 years on average, earnings per share has fallen by 27% per year but the company’s share price has only fallen by 3% per year, which means it has not declined as severely as earnings. Annuncio • Sep 21
Create Medic Co., Ltd. to Report Q3, 2024 Results on Oct 31, 2024 Create Medic Co., Ltd. announced that they will report Q3, 2024 results on Oct 31, 2024 Declared Dividend • Aug 07
Dividend of JP¥20.00 announced Shareholders will receive a dividend of JP¥20.00. Ex-date: 27th December 2024 Payment date: 1st January 1970 Dividend yield will be 4.1%, which is higher than the industry average of 1.0%. Sustainability & Growth Dividend is not covered by earnings (401% earnings payout ratio) nor is it covered by cash flows (132% cash payout ratio). The dividend has increased over the past 10 years and has been stable with no material reductions to payments, indicating a long track record of dividend growth and stability. The company's earnings per share (EPS) would need to grow by 345% to bring the payout ratio under control. However, EPS has declined by 32% over the last 5 years so the company would need to reverse this trend. Upcoming Dividend • Jun 20
Upcoming dividend of JP¥19.00 per share Eligible shareholders must have bought the stock before 27 June 2024. Payment date: 09 September 2024. The company is paying out more than 100% of its earnings and cash flow. Trailing yield: 3.8%. Within top quartile of Japanese dividend payers (3.4%). Higher than average of industry peers (1.0%). Annuncio • Jun 06
Create Medic Co., Ltd. to Report Q2, 2024 Results on Aug 05, 2024 Create Medic Co., Ltd. announced that they will report Q2, 2024 results on Aug 05, 2024 Reported Earnings • May 08
First quarter 2024 earnings released: EPS: JP¥6.51 (vs JP¥14.18 in 1Q 2023) First quarter 2024 results: EPS: JP¥6.51 (down from JP¥14.18 in 1Q 2023). Revenue: JP¥2.98b (up 3.7% from 1Q 2023). Net income: JP¥59.0m (down 54% from 1Q 2023). Profit margin: 2.0% (down from 4.5% in 1Q 2023). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has fallen by 53% per year but the company’s share price has only fallen by 2% per year, which means it has not declined as severely as earnings. Declared Dividend • Apr 20
Final dividend of JP¥19.00 announced Shareholders will receive a dividend of JP¥19.00. Ex-date: 27th June 2024 Payment date: 9th September 2024 Dividend yield will be 3.9%, which is higher than the industry average of 1.0%. Sustainability & Growth Dividend is not covered by earnings (219% earnings payout ratio) nor is it covered by cash flows (135% cash payout ratio). The dividend has increased over the past 10 years and has been stable with no material reductions to payments, indicating a long track record of dividend growth and stability. The company's earnings per share (EPS) would need to grow by 143% to bring the payout ratio under control. However, EPS has declined by 25% over the last 5 years so the company would need to reverse this trend. Annuncio • Mar 01
Create Medic Co., Ltd. to Report Q1, 2024 Results on May 07, 2024 Create Medic Co., Ltd. announced that they will report Q1, 2024 results on May 07, 2024 Reported Earnings • Feb 19
Full year 2023 earnings released: EPS: JP¥16.92 (vs JP¥50.56 in FY 2022) Full year 2023 results: EPS: JP¥16.92 (down from JP¥50.56 in FY 2022). Revenue: JP¥12.6b (up 2.7% from FY 2022). Net income: JP¥154.0m (down 67% from FY 2022). Profit margin: 1.2% (down from 3.8% in FY 2022). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has fallen by 41% per year but the company’s share price has remained flat, which means it is well ahead of earnings. Annuncio • Dec 27
Create Medic Co., Ltd. to Report Fiscal Year 2023 Results on Feb 14, 2024 Create Medic Co., Ltd. announced that they will report fiscal year 2023 results on Feb 14, 2024 Upcoming Dividend • Dec 21
Upcoming dividend of JP¥20.00 per share at 4.1% yield Eligible shareholders must have bought the stock before 28 December 2023. Payment date: 01 April 2024. The company is not currently making a profit and is not cash flow positive. Trailing yield: 4.1%. Within top quartile of Japanese dividend payers (3.5%). Higher than average of industry peers (1.0%). Reported Earnings • Nov 02
Third quarter 2023 earnings released: JP¥33.72 loss per share (vs JP¥25.61 profit in 3Q 2022) Third quarter 2023 results: JP¥33.72 loss per share (down from JP¥25.61 profit in 3Q 2022). Revenue: JP¥3.14b (flat on 3Q 2022). Net loss: JP¥307.0m (down 232% from profit in 3Q 2022). Over the last 3 years on average, earnings per share has fallen by 30% per year but the company’s share price has only fallen by 4% per year, which means it has not declined as severely as earnings. Annuncio • Sep 17
Create Medic Co., Ltd. to Report Q3, 2023 Results on Oct 31, 2023 Create Medic Co., Ltd. announced that they will report Q3, 2023 results on Oct 31, 2023 New Risk • Aug 08
New major risk - Revenue and earnings growth Earnings have declined by 2.5% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 2.5% per year over the past 5 years. Minor Risks Paying a dividend despite having no free cash flows. Market cap is less than US$100m (JP¥8.03b market cap, or US$56.1m). Reported Earnings • Aug 08
Second quarter 2023 earnings released: EPS: JP¥20.54 (vs JP¥19.67 in 2Q 2022) Second quarter 2023 results: EPS: JP¥20.54 (up from JP¥19.67 in 2Q 2022). Revenue: JP¥3.16b (up 1.7% from 2Q 2022). Net income: JP¥187.0m (up 4.5% from 2Q 2022). Profit margin: 5.9% (in line with 2Q 2022). Over the last 3 years on average, earnings per share has fallen by 14% per year but the company’s share price has only fallen by 4% per year, which means it has not declined as severely as earnings. Upcoming Dividend • Jun 22
Upcoming dividend of JP¥17.00 per share at 4.1% yield Eligible shareholders must have bought the stock before 29 June 2023. Payment date: 08 September 2023. Payout ratio is a comfortable 74% but the company is paying out more than the cash it is generating. Trailing yield: 4.1%. Within top quartile of Japanese dividend payers (3.5%). Higher than average of industry peers (0.9%). Annuncio • Jun 01
Create Medic Co., Ltd. to Report Q2, 2023 Results on Aug 04, 2023 Create Medic Co., Ltd. announced that they will report Q2, 2023 results on Aug 04, 2023 Reported Earnings • May 10
First quarter 2023 earnings released: EPS: JP¥14.18 (vs JP¥14.51 in 1Q 2022) First quarter 2023 results: EPS: JP¥14.18 (down from JP¥14.51 in 1Q 2022). Revenue: JP¥2.87b (down 2.0% from 1Q 2022). Net income: JP¥129.0m (down 2.3% from 1Q 2022). Profit margin: 4.5% (in line with 1Q 2022). Over the last 3 years on average, earnings per share has fallen by 10% per year but the company’s share price has only fallen by 3% per year, which means it has not declined as severely as earnings. Annuncio • Feb 15
Create Medic Co., Ltd., Annual General Meeting, Mar 30, 2023 Create Medic Co., Ltd., Annual General Meeting, Mar 30, 2023. Reported Earnings • Feb 15
Full year 2022 earnings released: EPS: JP¥50.56 (vs JP¥72.57 in FY 2021) Full year 2022 results: EPS: JP¥50.56 (down from JP¥72.57 in FY 2021). Revenue: JP¥12.3b (up 4.8% from FY 2021). Net income: JP¥460.0m (down 30% from FY 2021). Profit margin: 3.8% (down from 5.6% in FY 2021). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has fallen by 6% per year and the company’s share price has also fallen by 6% per year. Annuncio • Feb 13
Create Medic Co., Ltd. Announces Dividend for the Year Ended December 31, 2023, Payable on March 31, 2023 and Provides Dividend Guidance for the Second Quarter and Year End of Fiscal Year Ending December 31, 2023 Create Medic Co., Ltd. announced dividend for the year ended December 31, 2022 of JPY 20.00 payable on March 31, 2023 also provided dividend guidance for the second quarter and year end of fiscal year ending December 31, 2023 of JPY 17.00 per share and JPY 20.00 per share. Buying Opportunity • Feb 07
Now 20% undervalued Over the last 90 days, the stock is up 1.7%. The fair value is estimated to be JP¥1,109, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 5.3% over the last 3 years, while earnings per share has been flat. Upcoming Dividend • Dec 22
Upcoming dividend of JP¥20.00 per share Eligible shareholders must have bought the stock before 29 December 2022. Payment date: 31 March 2023. Payout ratio is a comfortable 55% and this is well supported by cash flows. Trailing yield: 4.2%. Within top quartile of Japanese dividend payers (3.8%). Higher than average of industry peers (1.1%). Annuncio • Dec 18
Create Medic Co., Ltd. to Report Fiscal Year 2022 Results on Feb 13, 2023 Create Medic Co., Ltd. announced that they will report fiscal year 2022 results on Feb 13, 2023 Board Change • Nov 16
Less than half of directors are independent No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 4 experienced directors. 6 highly experienced directors. 3 independent directors (7 non-independent directors). Executive Officer, Manager of Overall Administration Department & Director Atsushi Hashii was the last director to join the board, commencing their role in 2014. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment. Reported Earnings • Nov 02
Third quarter 2022 earnings released: EPS: JP¥25.61 (vs JP¥20.67 in 3Q 2021) Third quarter 2022 results: EPS: JP¥25.61 (up from JP¥20.67 in 3Q 2021). Revenue: JP¥3.14b (up 10.0% from 3Q 2021). Net income: JP¥233.0m (up 24% from 3Q 2021). Profit margin: 7.4% (up from 6.6% in 3Q 2021). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 1% per year whereas the company’s share price has fallen by 6% per year. Annuncio • Aug 28
Create Medic Co., Ltd. to Report Q3, 2022 Results on Oct 31, 2022 Create Medic Co., Ltd. announced that they will report Q3, 2022 results on Oct 31, 2022 Reported Earnings • Aug 05
Second quarter 2022 earnings released: EPS: JP¥19.67 (vs JP¥29.91 in 2Q 2021) Second quarter 2022 results: EPS: JP¥19.67 (down from JP¥29.91 in 2Q 2021). Revenue: JP¥3.10b (up 7.0% from 2Q 2021). Net income: JP¥179.0m (down 34% from 2Q 2021). Profit margin: 5.8% (down from 9.4% in 2Q 2021). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 2% per year and the company’s share price has also increased by 2% per year. Upcoming Dividend • Jun 22
Upcoming dividend of JP¥17.00 per share Eligible shareholders must have bought the stock before 29 June 2022. Payment date: 08 September 2022. Payout ratio is a comfortable 51% and this is well supported by cash flows. Trailing yield: 3.8%. Within top quartile of Japanese dividend payers (3.8%). Higher than average of industry peers (1.1%). Annuncio • May 29
Create Medic Co., Ltd. to Report Q2, 2022 Results on Aug 04, 2022 Create Medic Co., Ltd. announced that they will report Q2, 2022 results on Aug 04, 2022 Reported Earnings • May 11
First quarter 2022 earnings released: EPS: JP¥14.51 (vs JP¥14.95 in 1Q 2021) First quarter 2022 results: EPS: JP¥14.51 (down from JP¥14.95 in 1Q 2021). Revenue: JP¥2.93b (up 13% from 1Q 2021). Net income: JP¥132.0m (down 2.9% from 1Q 2021). Profit margin: 4.5% (down from 5.3% in 1Q 2021). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 6% per year whereas the company’s share price has increased by 2% per year. Board Change • Apr 27
Less than half of directors are independent No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 4 experienced directors. 7 highly experienced directors. 3 independent directors (8 non-independent directors). Executive Officer, Manager of Overall Administration Department & Director Atsushi Hashii was the last director to join the board, commencing their role in 2014. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment. Annuncio • Feb 27
Create Medic Co., Ltd. to Report Q1, 2022 Results on May 06, 2022 Create Medic Co., Ltd. announced that they will report Q1, 2022 results on May 06, 2022 Reported Earnings • Feb 12
Full year 2021 earnings: Revenues and EPS in line with analyst expectations Full year 2021 results: EPS: JP¥72.57 (up from JP¥71.13 in FY 2020). Revenue: JP¥11.7b (up 8.0% from FY 2020). Net income: JP¥660.0m (flat on FY 2020). Profit margin: 5.6% (down from 6.1% in FY 2020). The decrease in margin was driven by higher expenses. Revenue was in line with analyst estimates. Over the last 3 years on average, earnings per share has increased by 7% per year but the company’s share price has remained flat, which means it is significantly lagging earnings. Upcoming Dividend • Dec 22
Upcoming dividend of JP¥20.00 per share Eligible shareholders must have bought the stock before 29 December 2021. Payment date: 31 March 2022. Payout ratio is a comfortable 39% and this is well supported by cash flows. Trailing yield: 3.7%. Within top quartile of Japanese dividend payers (3.3%). Higher than average of industry peers (0.7%). Reported Earnings • Oct 29
Third quarter 2021 earnings released: EPS JP¥20.67 (vs JP¥14.28 in 3Q 2020) The company reported a strong third quarter result with improved earnings, revenues and profit margins. Third quarter 2021 results: Revenue: JP¥2.85b (up 7.8% from 3Q 2020). Net income: JP¥188.0m (up 41% from 3Q 2020). Profit margin: 6.6% (up from 5.0% in 3Q 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 12% per year but the company’s share price has fallen by 3% per year, which means it is significantly lagging earnings. Reported Earnings • Aug 06
Second quarter 2021 earnings released: EPS JP¥29.91 (vs JP¥25.87 in 2Q 2020) The company reported a strong second quarter result with improved earnings, revenues and profit margins. Second quarter 2021 results: Revenue: JP¥2.90b (up 5.0% from 2Q 2020). Net income: JP¥272.0m (up 13% from 2Q 2020). Profit margin: 9.4% (up from 8.7% in 2Q 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 11% per year but the company’s share price has fallen by 10% per year, which means it is significantly lagging earnings. Upcoming Dividend • Jun 22
Upcoming dividend of JP¥17.00 per share Eligible shareholders must have bought the stock before 29 June 2021. Payment date: 08 September 2021. Trailing yield: 3.7%. Within top quartile of Japanese dividend payers (3.1%). Higher than average of industry peers (0.7%). Reported Earnings • May 08
First quarter 2021 earnings released: EPS JP¥14.95 (vs JP¥0.75 in 1Q 2020) The company reported a strong first quarter result with improved earnings, revenues and profit margins. First quarter 2021 results: Revenue: JP¥2.58b (up 11% from 1Q 2020). Net income: JP¥136.0m (up JP¥129.0m from 1Q 2020). Profit margin: 5.3% (up from 0.3% in 1Q 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 10% per year but the company’s share price has fallen by 10% per year, which means it is significantly lagging earnings. Reported Earnings • Apr 05
Full year 2020 earnings released: EPS JP¥71.13 (vs JP¥77.83 in FY 2019) The company reported a poor full year result with weaker earnings and profit margins, although revenues were flat. Full year 2020 results: Revenue: JP¥10.8b (flat on FY 2019). Net income: JP¥659.0m (down 9.1% from FY 2019). Profit margin: 6.1% (down from 6.7% in FY 2019). Over the last 3 years on average, earnings per share has increased by 10% per year but the company’s share price has fallen by 4% per year, which means it is significantly lagging earnings. Annuncio • Mar 03
Create Medic Co., Ltd. to Report Q1, 2021 Results on May 06, 2021 Create Medic Co., Ltd. announced that they will report Q1, 2021 results on May 06, 2021 Reported Earnings • Feb 14
Full year 2020 earnings released: EPS JP¥71.13 (vs JP¥77.83 in FY 2019) The company reported a poor full year result with weaker earnings and profit margins, although revenues were flat. Full year 2020 results: Revenue: JP¥10.8b (flat on FY 2019). Net income: JP¥659.0m (down 9.1% from FY 2019). Profit margin: 6.1% (down from 6.7% in FY 2019). Over the last 3 years on average, earnings per share has increased by 10% per year but the company’s share price has fallen by 4% per year, which means it is significantly lagging earnings. Annuncio • Feb 10
Create Medic Co., Ltd., Annual General Meeting, Mar 30, 2021 Create Medic Co., Ltd., Annual General Meeting, Mar 30, 2021. Upcoming Dividend • Dec 22
Upcoming Dividend of JP¥20.00 Per Share Will be paid on the 30th of March to those who are registered shareholders by the 29th of December. The trailing yield of 3.6% is in the top quartile of Japanese dividend payers (3.0%), and it is higher than industry peers (0.7%). Annuncio • Dec 05
Create Medic Co., Ltd. to Report Fiscal Year 2020 Results on Feb 10, 2021 Create Medic Co., Ltd. announced that they will report fiscal year 2020 results on Feb 10, 2021 Is New 90 Day High Low • Dec 01
New 90-day low: JP¥958 The company is down 3.0% from its price of JP¥984 on 02 September 2020. The Japanese market is up 8.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Medical Equipment industry, which is up 12% over the same period. Annuncio • Sep 03
Create Medic Co., Ltd. to Report Q3, 2020 Results on Oct 29, 2020 Create Medic Co., Ltd. announced that they will report Q3, 2020 results on Oct 29, 2020 
